Scott Walshko
President and CEO, FATE Therapeutics
Replay available
Fate Therapeutics, Inc. (FATE) Q1 2024 Earnings Call
Fate Therapeutics, Inc. (NASDAQ: FATE) Q1 2024 earnings conference call, held 2024-05-09. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ed Duloc
Chief Financial Officer, FATE Therapeutics
Michael Yee
Analyst, Jefferies
Dr. Bob Ballamer
Chief Research and Development Officer, FATE Therapeutics
Amin An
Analyst, Citi
Lee Watzick
Analyst, Cantor Fitzgerald
Carolina Ibanez-Ventoso
Analyst, Stiefel
Yanan Zhu
Analyst, Wells Fargo Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fate Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.490 Welcome to the FATE Therapeutics First Quarter 2024 Financial Results Conference Call. 00:00:05.490 -- 00:00:08.631 At this time, all participants are in listen-only mode. 00:00:08.631 -- 00:00:15.171 This call is being webcast live on the Investor Sections of FATE's website at FATEtherapeutics.com. 00:00:15.752 -- 00:00:19.172 As a reminder, today's call is also being recorded. 00:00:19.172 -- 00:00:24.373 I would now like to introduce Scott Walshko, President and CEO 00:00:24.373 -- 00:00:26.134 of FATE Therapeutics. Please go ahead. 00:00:26.134 -- 00:00:27.854 Thank 00:00:27.854 -- 00:00:32.919 you. Good afternoon, and thanks, everyone, for joining us for the Faith Therapeutics 00:00:32.919 -- 00:00:35.240 first quarter 2024 00:00:35.240 -- 00:00:38.662 financial results call. Shortly after 4 p.m. 00:00:38.662 -- 00:00:43.684 Eastern time today, we issued a press release with these results, which can be found 00:00:43.684 -- 00:00:47.546 on the investor section of our website under press releases. 00:00:47.546 -- 00:00:53.908 In addition, our Form 10-Q for the quarter ended March 31, 2024, was filed shortly thereafter. 00:00:55.566 -- 00:01:00.869 and can be found on the Investors section of our website under Financial Information. 00:01:00.869 -- 00:01:05.312 Before we begin, I would like to remind everyone that except for statements of historical 00:01:05.312 -- 00:01:10.735 facts, the statements made by management and responses to questions on this conference 00:01:10.735 -- 00:01:15.758 call are forward-looking statements under the safe harbor provisions 00:01:15.758 -- 00:01:20.889 of the Private Securities Litigation Reform Act of 1995. 00:01:20.961 -- 00:01:25.963 These statements involve risks and uncertainties, that ca...